Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BOSENTAN vs DABRAFENIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BOSENTAN vs DABRAFENIB: Safety Overview

Metric BOSENTAN DABRAFENIB
Total FAERS Reports 19,581 19,305
Deaths Reported 4,346 4,165
Death Rate 22.2% 21.6%
Hospitalizations 8,862 5,325
Average Patient Age 52.5 yrs 58.3 yrs
% Female Patients 73.2% 48.0%
FDA Approval Date Apr 26, 2019 Mar 16, 2023
Manufacturer Actelion Pharmaceuticals US, Inc. Novartis Pharmaceuticals Corporation
Route ORAL ORAL
Marketing Status Prescription Prescription